These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 9754904)
1. The inhibitory effect of ursodeoxycholic acid and pentoxifylline on platelet derived growth factor-stimulated proliferation is distinct from an effect by cyclic AMP. Peterson TC; Slysz G; Isbrucker R Immunopharmacology; 1998 Jun; 39(3):181-91. PubMed ID: 9754904 [TBL] [Abstract][Full Text] [Related]
2. In vitro effect of platelet-derived growth factor on fibroproliferation and effect of cytokine antagonists. Peterson TC; Isbrucker RA; Hooper ML Immunopharmacology; 1994; 28(3):259-70. PubMed ID: 7852056 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of fibroproliferation by pentoxifylline. Activity of metabolite-1 and lack of role of adenosine receptors. Peterson TC Biochem Pharmacol; 1996 Aug; 52(4):597-602. PubMed ID: 8759032 [TBL] [Abstract][Full Text] [Related]
10. The functional interaction of EGF and PDGF with bradykinin in the proliferation of human gingival fibroblasts. McAllister BS; Leeb-Lundberg F; Mellonig JT; Olson MS J Periodontol; 1995 Jun; 66(6):429-37. PubMed ID: 7562331 [TBL] [Abstract][Full Text] [Related]
11. Ursodeoxycholate and tauroursodeoxycholate inhibit cholangiocyte growth and secretion of BDL rats through activation of PKC alpha. Alpini G; Baiocchi L; Glaser S; Ueno Y; Marzioni M; Francis H; Phinizy JL; Angelico M; Lesage G Hepatology; 2002 May; 35(5):1041-52. PubMed ID: 11981754 [TBL] [Abstract][Full Text] [Related]
12. Cyclic AMP inhibitors inhibits PDGF-stimulated mitogen-activated protein kinase activity in rat aortic smooth muscle cells via inactivation of c-Raf-1 kinase and induction of MAP kinase phosphatase-1. Plevin R; Malarkey K; Aidulis D; McLees A; Gould GW Cell Signal; 1997; 9(3-4):323-8. PubMed ID: 9218135 [TBL] [Abstract][Full Text] [Related]
13. Ursodeoxycholic acid stimulates cholangiocyte fluid secretion in mice via CFTR-dependent ATP secretion. Fiorotto R; Spirlì C; Fabris L; Cadamuro M; Okolicsanyi L; Strazzabosco M Gastroenterology; 2007 Nov; 133(5):1603-13. PubMed ID: 17983806 [TBL] [Abstract][Full Text] [Related]
14. Platelet-derived growth factor and pentoxifylline modulation of collagen synthesis in myofibroblasts. Isbrucker RA; Peterson TC Toxicol Appl Pharmacol; 1998 Mar; 149(1):120-6. PubMed ID: 9512734 [TBL] [Abstract][Full Text] [Related]
15. Ursodeoxycholic acid but not tauroursodeoxycholic acid inhibits proliferation and differentiation of human subcutaneous adipocytes. Mališová L; Kováčová Z; Koc M; Kračmerová J; Stich V; Rossmeislová L PLoS One; 2013; 8(12):e82086. PubMed ID: 24312631 [TBL] [Abstract][Full Text] [Related]
16. Zedoariae rhizoma and curcumin inhibits platelet-derived growth factor-induced proliferation of human hepatic myofibroblasts. Park SD; Jung JH; Lee HW; Kwon YM; Chung KH; Kim MG; Kim CH Int Immunopharmacol; 2005 Mar; 5(3):555-69. PubMed ID: 15683851 [TBL] [Abstract][Full Text] [Related]
18. Effect of fetuin, a TGFbeta antagonist and pentoxifylline, a cytokine antagonist on hepatic stellate cell function and fibrotic parameters in fibrosis. Verma-Gandhu M; Peterson MR; Peterson TC Eur J Pharmacol; 2007 Oct; 572(2-3):220-7. PubMed ID: 17678645 [TBL] [Abstract][Full Text] [Related]
19. Ursodeoxycholic acid and tauroursodeoxycholic acid suppress choroidal neovascularization in a laser-treated rat model. Woo SJ; Kim JH; Yu HG J Ocul Pharmacol Ther; 2010 Jun; 26(3):223-9. PubMed ID: 20565307 [TBL] [Abstract][Full Text] [Related]
20. Tauroursodeoxycholic acid exerts anticholestatic effects by a cooperative cPKC alpha-/PKA-dependent mechanism in rat liver. Wimmer R; Hohenester S; Pusl T; Denk GU; Rust C; Beuers U Gut; 2008 Oct; 57(10):1448-54. PubMed ID: 18583398 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]